​

Funding Round

Series A - Evvy

Series A - Evvy

Investment Firm

Overview

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

Announced Date

Sep 27, 2023

Closed on Date

Sep 27, 2023

Funding Type

Series A

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Left Lane Capital

Left Lane Capital

Left Lane Capital is a debt and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorVirtue
Participant InvestorAmboy Street Ventures
Participant InvestorLabCorp Venture Fund
Participant InvestorLeft Lane Capital
Participant InvestorGeneral Catalyst

Round Details and Background

Evvy raised $14000000 on 2023-09-27 in Series A

Evvy develops at-home vaginal microbiome tests using metagenomic sequencing to understand symptoms and risks for critical health challenges.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 14, 2021
Seed Round - Evvy
6-5.0M
Sep 27, 2023
Series A - Evvy
8-14.0M

Recent Activity

There is no recent news or activity for this profile.